Tagged with Pricing

Forging a New Path to Commercialization for Cell and Gene Therapies
Shooting For the Stars: The Evolution in Outcome-Based Payment Models for Medicines
Further Predictions for 2019 – Tech, Value-Based Pricing & Emerging Markets
The Future of Biosimilars in the USA
Government Sector Organisations: France
China Healthcare in 2019: Sprinting a Marathon
How Beneficial Is The Recent Price Control Exemption For Innovative Drugs In India?
The IFPMA’s New Code of Practice: PharmaBoardroom Readers Have Their Say
The UK to Incentivise Big Pharma Firms to Develop New Antibiotics
4+7: China’s New Volume-Based Purchasing Policy
Healthcare Politics in 2019
Maurice-Pierre Planel – President, CEPS, France
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here